These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26327465)

  • 1. Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy.
    Sittivarakul W; Benjhawaleemas T; Aui-Aree N; Jirarattanasopa P; Liabsuetrakul T
    Ocul Immunol Inflamm; 2016 Oct; 24(5):530-6. PubMed ID: 26327465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Rates and Risk Factors for Vision Loss among AIDS-Related Cytomegalovirus Retinitis Patients in Southern Thailand.
    Sittivarakul W; Seepongphun U
    Ocul Immunol Inflamm; 2018; 26(1):82-89. PubMed ID: 28323489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy.
    Sittivarakul W; Benjhawaleemas T; Aui-Aree N; Jirarattanasopa P; Liabsuetrakul T
    Ocul Immunol Inflamm; 2015 Aug; ():1-7. PubMed ID: 26258284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
    Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
    Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
    Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
    Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
    Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
    Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral Eye Involvement and Retinal Detachment in Patients with Cytomegalovirus Retinitis Treated with Intravitreous Ganciclovir.
    Ausayakhun S; Lu LJ; Ausayakuhn S; Nanegrungsunk O; Apivatthakakul A; Luewattananont D; Photcharapongsakul C; Liu Y; Holland GN; Margolis TP; Heiden D; Keenan JD
    Ocul Immunol Inflamm; 2021 Aug; 29(6):1145-1150. PubMed ID: 32275186
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
    Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen.
    Teoh SC; Ou X; Lim TH
    Ophthalmology; 2012 Mar; 119(3):588-95. PubMed ID: 22137552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
    Oktavec KC; Nolan K; Brown DM; Dunn JP; Livingston AG; Thorne JE
    Am J Ophthalmol; 2012 Apr; 153(4):728-33, 733.e1-2. PubMed ID: 22265144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
    Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
    Martin BK; Ricks MO; Forman MS; Jabs DA;
    Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
    Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field loss in patients with cytomegalovirus retinitis.
    Thorne JE; Van Natta ML; Jabs DA; Duncan JL; Srivastava SK;
    Ophthalmology; 2011 May; 118(5):895-901. PubMed ID: 21146225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
    Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.